No Data
No Data
Lonza Group Names New CEO
Lonza Group AG (SGX:O6Z) has appointed Wolfgang Wienand as its new chief executive officer, according to a Tuesday filing on the Singapore Exchange. This change follows Albert Baehny's departure, mark
Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug
Acumen Pharmaceuticals (ABOS) said Thursday that it has signed a collaboration agreement with healthcare manufacturing organization Lonza to develop and commercialize sabirnetug to treat Alzheimer's d
Lonza CEO Appointment to Be Well Received -- Market Talk
0735 GMT - Lonza Group's appointment of Wolfgang Wienand as its new CEO will likely get a favorable market reaction given that he is an external candidate who brings a wealth of experience in the drug
Lonza Group Appoints New CEO; Seeks Lifting of Trading Halt
Lonza Group (SGX:O6Z) appointed Wolfgang Wienand as chief executive, succeeding Albert Baehny, according to a Singapore bourse filing on Tuesday. Wienand, who will join the drug manufacturing company
Singaporean Shares Rise Tracking Global Gains; Top Glove's Shares Up 9% as Losses Shrink
Singapore shares finished marginally higher on Wednesday, following overnight gains in global markets. During the day, the benchmark Singapore Strait Times Index ranged between 3,174.13 and 3,188.06,
Lonza Group to Acquire Biologics Site in US for $1.2 Billion
Lonza Group (SGX:O6Z) agreed to acquire the Genentech manufacturing facility in Vacaville, US, from multinational healthcare company Roche for $1.2 billion, according to a filing with the Singapore ex
No Data